Shares of diabetes device makers fell as the US CMS proposed scaling back insurance coverage for CGMs and insulin pumps, raising concerns over pricing and profitability.
#YonhapInfomax #DiabetesTechnology #CMS #Dexcom #InsulinPump #CompetitiveBidding #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=70292